Dissecting Kawasaki disease: a state-of-the-art review

S M Dietz1, D van Stijn2, D Burgner3,4,5

  • 1Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Childrens Hospital, Academic Medical Centre (AMC), Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. s.m.dietz@amc.nl.

Insights

Kawasaki disease (KD) is a pediatric vasculitis causing coronary artery aneurysms (CAA). While IVIG is standard treatment, 10-20% of patients require further therapy, and long-term cardiovascular risk requires ongoing study.

Area of Science:

  • Pediatric rheumatology
  • Immunology
  • Cardiology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired pediatric heart disease.
  • It presents with persistent fever and systemic inflammation, primarily affecting coronary arteries.
  • Coronary artery aneurysms (CAA) are the main complication, potentially leading to myocardial infarction.

Purpose of the Study:

  • To review the current understanding of KD etiology, diagnosis, and management.
  • To highlight the challenges in treating non-responsive KD cases.
  • To emphasize the importance of long-term cardiovascular risk assessment in KD survivors.

Main Methods:

  • Review of existing literature on Kawasaki disease.
  • Analysis of diagnostic criteria and imaging techniques (echocardiography).
  • Discussion of treatment protocols, including intravenous immunoglobulin (IVIG) and alternative therapies.

Main Results:

  • KD diagnosis relies on fever and specific clinical signs.
  • Echocardiography is crucial for detecting and monitoring CAA using diameter and z-scores.
  • 10-20% of patients exhibit resistance to standard IVIG treatment, necessitating further interventions.

Conclusions:

  • Despite advances, KD etiology remains incompletely understood, with genetic factors like the ITPKC pathway gaining attention.
  • Long-term follow-up is crucial as KD patients transition to adulthood.
  • Understanding the long-term cardiovascular risks associated with KD and CAA is an evolving area of research.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
776
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
647
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338